Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202346
Company: PHARMOBEDIENT

Products on ANDA 202346

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202346

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/07/2015	ORIG-1	Approval			Review (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/202346Orig1s000.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/02/2019	SUPPL-12	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 202346

LIDOCAINE

PATCH;TOPICAL; 5%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	200675	ACTAVIS LABS UT INC
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	216484	ALKEM LABS LTD
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	206463	AMNEAL
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	209190	IBSA
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	205882	NAL PHARM
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	202346	PHARMOBEDIENT
LIDOCAINE	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	No	AB	207059	USPHARMA
LIDODERM	LIDOCAINE	5%	PATCH;TOPICAL	Prescription	Yes	AB	020612	TEIKOKU PHARMA USA